Literature DB >> 11472392

Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets.

P Aukrust, J K Damås, L Gullestad, S S Frøland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11472392      PMCID： PMC1906089          DOI： 10.1046/j.1365-2249.2001.01527.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  34 in total

Review 1.  Chemokines, leukocytes, and atherosclerosis.

Authors:  R E Gerszten; F Mach; A Sauty; A Rosenzweig; A D Luster
Journal:  J Lab Clin Med       Date:  2000-08

Review 2.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 3.  Chemokine receptors and their role in inflammation and infectious diseases.

Authors:  C Murdoch; A Finn
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

4.  Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart.

Authors:  T Kakio; A Matsumori; K Ono; H Ito; K Matsushima; S Sasayama
Journal:  Lab Invest       Date:  2000-07       Impact factor: 5.662

5.  Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure.

Authors:  L Gullestad; P Aukrust; T Ueland; T Espevik; G Yee; R Vagelos; S S Frøland; M Fowler
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

6.  Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure.

Authors:  J K Damås; H G Eiken; E Oie; V Bjerkeli; A Yndestad; T Ueland; T Tonnessen; O R Geiran; H Aass; S Simonsen; G Christensen; S S Froland; H Attramadal; L Gullestad; P Aukrust
Journal:  Cardiovasc Res       Date:  2000-09       Impact factor: 10.787

7.  Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure.

Authors:  T M Behr; X Wang; N Aiyar; R W Coatney; X Li; P Koster; C E Angermann; E Ohlstein; G Z Feuerstein; J Winaver
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

8.  Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes.

Authors:  P Aukrust; R K Berge; T Ueland; E Aaser; J K Damås; L Wikeby; A Brunsvig; F Müller; K Forfang; S S Frøland; L Gullestad
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

9.  Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop.

Authors:  T Yamamoto; B Eckes; C Mauch; K Hartmann; T Krieg
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

10.  A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.

Authors:  F G Spinale; M L Coker; L J Heung; B R Bond; H R Gunasinghe; T Etoh; A T Goldberg; J L Zellner; A J Crumbley
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690
View more
  11 in total

1.  β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4.

Authors:  Thomas J LaRocca; Martina Schwarzkopf; Perry Altman; Shihong Zhang; Achla Gupta; Ivone Gomes; Zikiar Alvin; Hunter C Champion; Georges Haddad; Roger J Hajjar; Lakshmi A Devi; Alison D Schecter; Sima T Tarzami
Journal:  J Cardiovasc Pharmacol       Date:  2010-11       Impact factor: 3.105

2.  CXCR4 modulates contractility in adult cardiac myocytes.

Authors:  Robert T Pyo; Jinliang Sui; Ashwini Dhume; Julieta Palomeque; Burns C Blaxall; George Diaz; James Tunstead; Diomedes E Logothetis; Roger J Hajjar; Alison D Schecter
Journal:  J Mol Cell Cardiol       Date:  2006-09-28       Impact factor: 5.000

3.  Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy.

Authors:  Jianli Niu; Asim Azfer; Pappachan E Kolattukudy
Journal:  Cardiovasc Res       Date:  2006-03-16       Impact factor: 10.787

4.  Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.

Authors:  Edecio Cunha-Neto; Victor J Dzau; Paul D Allen; Dimitri Stamatiou; Luiz Benvenutti; M Lourdes Higuchi; Natalia S Koyama; Joao S Silva; Jorge Kalil; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 5.  Reappraising the role of inflammation in heart failure.

Authors:  Luigi Adamo; Cibele Rocha-Resende; Sumanth D Prabhu; Douglas L Mann
Journal:  Nat Rev Cardiol       Date:  2020-01-22       Impact factor: 32.419

6.  Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.

Authors:  Jianli Niu; Asim Azfer; Michael F Deucher; Pascal J Goldschmidt-Clermont; Pappachan E Kolattukudy
Journal:  J Mol Cell Cardiol       Date:  2006-05-05       Impact factor: 5.000

7.  Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha.

Authors:  Preeti Misra; Djamel Lebeche; Hung Ly; Martina Schwarzkopf; George Diaz; Roger J Hajjar; Alison D Schecter; John V Frangioni
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

8.  Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts.

Authors:  Ayanna S Augustus; Jonathan Buchanan; Sankar Addya; Giuseppe Rengo; Richard G Pestell; Paolo Fortina; Walter J Koch; Andre Bensadoun; E Dale Abel; Michael P Lisanti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

9.  Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.

Authors:  Jana Petrkova; Jaroslava Szotkowska; Zuzana Hermanova; Jan Lukl; Martin Petrek
Journal:  Mediators Inflamm       Date:  2004-02       Impact factor: 4.711

Review 10.  Alteration of energy substrates and ROS production in diabetic cardiomyopathy.

Authors:  O Lorenzo; E Ramírez; B Picatoste; J Egido; J Tuñón
Journal:  Mediators Inflamm       Date:  2013-10-31       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.